| Alzheimer Disease |
1 |
1 |
| Aducanumab |
0 |
0.99 |
| Revenue and Practice Management |
0 |
0.53 |
| Medical Life |
0 |
0.33 |
| Brain |
0 |
0.23 |
| Medicare |
0 |
0.17 |
| Amyloid Plaque |
0 |
0.12 |
| Informed Consent |
0 |
0.12 |
| Shared Decision-Making |
0 |
0.1 |
| California |
0 |
0.06 |
| Child |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Clinician Health and Well-Being |
0 |
0.06 |
| Dementia |
0 |
0.06 |
| Financing |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Health Care Cost |
0 |
0.06 |
| Hemorrhage |
0 |
0.06 |
| Memory |
0 |
0.06 |
| Salary and Compensation |
0 |
0.06 |